2026年全球人工智慧（AI）遠端腫瘤放射劑量調度器市場報告

近年來，人工智慧驅動的遠端腫瘤放射劑量計劃軟體市場發展迅速。預計該市場規模將從2025年的8.1億美元成長到2026年的9.9億美元，複合年成長率（CAGR）高達23.3%。成長要素包括：對遠距癌症治療計畫的需求不斷成長、遠距腫瘤平台的廣泛應用、對精確放射劑量計算的需求不斷成長、人工智慧在腫瘤決策支援中的應用日益廣泛、全球癌症發病率上升、醫院數位化轉型取得進展、雲端醫療系統的廣泛應用、放射治療工作流程自動化需求的日益成長、對減少治療的廣泛治療以及減少智慧腫瘤排班工具的廣泛治療。

預計未來幾年，人工智慧（AI）遠距腫瘤放射劑量調度市場將大幅成長，到2030年將達到22.8億美元，複合年成長率（CAGR）為23.0%。預測期內的成長要素包括：遠端腫瘤網路的擴展、人工智慧驅動的治療計畫平台的普及、對自動化劑量運算系統需求的成長、基於雲端的腫瘤調度模組的廣泛應用、預測性腫瘤演算法的採用、遠距放射線治療治療評估工具的開發、對精準癌症治療的需求、人工智慧工具在腫瘤科室的整合、人工智慧供應商與癌症中心之間的合作，以及對癌症中心之間的遠距放射線治療流程的普及。預測期內的主要趨勢包括：人工智慧驅動的放射治療劑量預測的進步、基於雲端的腫瘤治療調度平台的進步、即時劑量最佳化引擎的進步、自動化治療計劃系統的創新、預測腫瘤算法的創新、虛擬放射腫瘤工作流程的創新、遠程腫瘤學和醫院資訊系統的整合、人工智慧劑量調度器和影片成像平台的整合腫瘤算法以及遠程劑量審查以及遠程遠距放射線治療的網路審查。

癌症發生率的上升預計將推動人工智慧（AI）遠端腫瘤放射劑量調度系統市場的成長。癌症是一種以異常細胞不受控制地增生和擴散為特徵的疾病，若不及時有效治療，會損害周圍組織和器官。不良飲食、吸煙、飲酒以及接觸環境污染物等生活方式相關風​​險因素正在加劇癌症發病率的上升以及患有各種癌症的風險。人工智慧（AI）遠端腫瘤放射劑量調度系統透過遠端數據驅動分析，最佳化和個人化放射治療方案，從而支持癌症管理。這些系統能夠確保精準的劑量輸送，減少治療延誤，並實現無論身處何地都能獲得一致的治療，進而改善患者的治療效果。例如，根據英國政府機構NHS Digital的數據，截至2025年10月，英格蘭地區2023年新增癌症病例354,820例，平均每天972例，比2022年增加8,605例。其中，攝護腺癌是最常見的新增病例，達58,137例，比上年度增加6%。因此，癌症發生率的上升正在推動人工智慧驅動的遠端腫瘤放射劑量調度系統市場的成長。

在人工智慧遠距腫瘤學和放射治療市場主要企業正致力於開發先進的解決方案，例如人工智慧驅動的劑量預測，以預測個人化的放射劑量分佈並簡化治療計劃。人工智慧驅動的劑量預測平台是一種軟體解決方案，它分析影像和解剖數據，產生臨床可行的3D劑量分佈，並支援及時調整以最佳化治療。例如，2025年3月，總部位於芬蘭的醫療科技公司MVision AI發表了「Dose+」。這款人工智慧驅動的劑量預測平台整合了專門針對前列腺癌和骨盆淋巴結病例的模型，能夠根據每位患者的解剖結構最佳化劑量分佈，並透過DICOM與標準治療計劃系統整合，從而實現高效的計劃工作流程。此次發布標誌著人工智慧驅動的劑量預測在融入常規臨床實踐方面取得了重大技術進步，它將傳統計劃與以患者為中心的自動化流程相結合，並為臨床醫生提供了擴充性且高效的解決方案，以實現精準的個人化放射治療。

目錄

第1章：執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球人工智慧（AI）遠端腫瘤放射劑量調度器市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 人工智慧（AI）和自主人工智慧
  • 生物技術、基因組學和精準醫療
  • 數位化、雲端運算、巨量資料、網路安全
  • 自主系統、機器人、智慧運輸
  • 物聯網、智慧基礎設施、互聯生態系統
• 主要趨勢
  • 遠端醫療計劃的最佳化
  • 預測性輻射劑量計劃
  • 自適應放射治療的整合
  • 臨床工作流程自動化
  • 人工智慧驅動的患者預後分析

第5章 終端用戶產業市場分析

• 醫院
• 癌症治療中心
• 研究機構
• 腫瘤診所
• 遠端醫療服務供應商

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球人工智慧（AI）遠端腫瘤放射劑量調度市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球人工智慧（AI）遠端腫瘤放射劑量調度器市場規模、對比及成長率分析
• 全球人工智慧（AI）遠端腫瘤放射劑量調度器市場表現：規模和成長，2020-2025年
• 全球人工智慧（AI）遠端腫瘤放射劑量調度市場預測：規模和成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

• 按組件
• 軟體、硬體和服務
• 透過技術
• 機器學習演算法、自然語言處理、電腦視覺、預測分析
• 部署模式
• 本地部署（本地部署）、雲端部署（SaaS）、混合部署
• 透過使用
• 自動勾勒輪廓和分割（危及器官或目標區）、治療計劃產生和最佳化、劑量預測和品質保證（QA）、工作流程和資源調度最佳化、自適應放射治療計劃。
• 最終用戶
• 醫院、癌症治療中心、研究機構和其他最終用戶
• 按類型細分：軟體
• 分析和報告軟體、建議引擎軟體、自然語言處理軟體、機器學習模型管理工具、電腦視覺軟體、整合和API管理軟體、行動和Web應用程式軟體
• 按類型細分：硬體
• 人工智慧最佳化伺服器、邊緣運算設備、感測器和物聯網設備、智慧攝影機、GPU 和人工智慧加速器、儲存系統、網路和連接硬體
• 按類型細分：服務
• 諮詢服務、實施和整合服務、培訓和支援服務、託管人工智慧服務、維護和升級服務、客製化人工智慧開發服務、資料管理和標註服務

第10章 區域與國別分析

• 全球人工智慧（AI）遠端腫瘤放射劑量調度市場：按地區分類，歷史資料及預測，2020-2025年、2025-2030年、2035年
• 全球人工智慧（AI）遠端腫瘤放射劑量調度市場：按國家分類，歷史資料及預測，2020-2025年、2025-2030年、2035年

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 人工智慧（AI）遠端腫瘤放射劑量調度市場：競爭格局和市場佔有率，2024年
• 人工智慧（AI）遠端腫瘤放射劑量調度市場：公司估值矩陣
• 人工智慧（AI）遠端腫瘤放射劑量調度市場：公司概況
  • IBM Corporation
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips NV
  • Varian Medical Systems Inc.

第37章 其他大型企業和創新企業

• Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., Accuray Incorporated, Brainlab AG, RaySearch Laboratories AB, MIM Software Inc., Sun Nuclear Corp., DeepHealth, Radformation Inc., MVision AI Ltd., Mirada Medical Ltd., ViewRay Inc., Oncora Medical, Enlitic, Optellum Ltd.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：具有高市場潛力的國家、細分市場與策略

• 2030年人工智慧（AI）遠端腫瘤放射劑量調度市場：提供新機會的國家
• 2030年人工智慧（AI）遠端腫瘤放射劑量調度市場：提供新機會的細分市場
• 2030年人工智慧（AI）遠端腫瘤放射劑量調度市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第41章附錄

An artificial intelligence (AI) tele-oncology radiation dose scheduler is a digital system that uses AI to assist clinicians in planning, adjusting, and optimizing radiation dose schedules remotely. It analyzes clinical, imaging, and treatment data to provide patient-specific dosing recommendations. This technology enhances accuracy, reduces planning time, and supports efficient remote oncology workflows.

The primary components of AI tele-oncology radiation dose schedulers consist of software, hardware, and services. Software includes AI-enabled scheduling and planning platforms that automate dose planning, coordinate workflows, and optimize resources for remote and centralized radiation oncology operations. These systems utilize technologies such as machine learning, natural language processing, computer vision, and predictive analytics, and are deployed through on-premises, cloud-based, and hybrid models. Applications include auto-contouring and segmentation, treatment plan generation and optimization, dose prediction and quality assurance, workflow and resource scheduling, and adaptive radiotherapy planning, used by hospitals, cancer treatment centers, research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have affected the ai tele-oncology radiation dose scheduler market by increasing the cost of importing ai-optimized servers, edge computing devices, and specialized radiotherapy hardware. this has slowed deployment in regions dependent on imported equipment, particularly in asia-pacific and latin america. segments such as hardware and ai software services are most impacted, while cloud-based deployment and remote consultation services may benefit from local alternatives. overall, tariffs have pushed manufacturers to explore localized production and diversified sourcing strategies to maintain market growth.

The artificial intelligence (AI) tele-oncology radiation dose scheduler market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) tele-oncology radiation dose scheduler market statistics, including artificial intelligence (AI) tele-oncology radiation dose scheduler industry global market size, regional shares, competitors with a artificial intelligence (AI) tele-oncology radiation dose scheduler market share, detailed artificial intelligence (AI) tele-oncology radiation dose scheduler market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) tele-oncology radiation dose scheduler industry. This artificial intelligence (AI) tele-oncology radiation dose scheduler market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI) tele-oncology radiation dose scheduler market size has grown expoentially in recent years. It will grow from $0.81 billion in 2025 to $0.99 billion in 2026 at a compound annual growth rate (CAGR) of 23.3%. The growth in the historic period can be attributed to increasing need for remote cancer treatment planning, rising adoption of tele-oncology platforms, growing demand for precise radiation dose calculation, increasing use of ai in oncology decision support, rising cancer incidence worldwide, growing digital transformation in hospitals, increasing deployment of cloud-based medical systems, rising need for workflow automation in radiotherapy, growing focus on reducing treatment errors, increasing adoption of smart oncology scheduling tools.

The artificial intelligence (AI) tele-oncology radiation dose scheduler market size is expected to see exponential growth in the next few years. It will grow to $2.28 billion in 2030 at a compound annual growth rate (CAGR) of 23.0%. The growth in the forecast period can be attributed to expansion of tele-oncology networks, adoption of ai-enabled treatment planning platforms, rising demand for automated dose calculation systems, uptake of cloud-based oncology scheduling modules, deployment of predictive oncology algorithms, development of remote radiotherapy review tools, demand for precision-based cancer care, integration of ai tools into oncology departments, partnerships between ai vendors and cancer centers, growing acceptance of tele-radiation workflows. Major trends in the forecast period include advancement in ai-driven radiotherapy dose prediction, advancement in cloud-based oncology scheduling platforms, advancement in real-time dose optimization engines, innovation in automated treatment planning systems, innovation in predictive oncology algorithms, innovation in virtual radiation oncology workflows, integration of tele-oncology with hospital info systems, integration of ai dose schedulers with imaging platforms, integration of remote dose-review tools for oncologists, integration of multi-center tele-radiation networks.

The rising prevalence of cancer is expected to propel the growth of the artificial intelligence (AI) tele-oncology radiation dose scheduler market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells that can damage surrounding tissues and organs if not treated effectively. The prevalence of cancer is increasing due to lifestyle-related risks such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, elevating the risk of developing various cancers. Artificial intelligence (AI) tele-oncology radiation dose schedulers support cancer management by optimizing and personalizing radiation treatment plans through remote, data-driven analysis. They improve patient outcomes by ensuring accurate dosing, reducing treatment delays, and enabling consistent care across locations. For instance, in October 2025, according to NHS Digital, a UK government organisation, there were 354,820 new cancer diagnoses recorded in England in 2023, averaging 972 diagnoses per day and representing an increase of 8,605 cases compared to 2022, with prostate cancer being the most commonly diagnosed at 58,137 new cases, reflecting a 6% increase in registrations compared to the previous year. Therefore, the rising prevalence of cancer is driving the growth of the artificial intelligence (AI) tele-oncology radiation dose scheduler market.

Key players operating in the AI tele-oncology and radiation therapy market are focusing on developing advanced solutions, such as AI-powered dose prediction, to predict personalized radiation dose distributions and improve treatment planning efficiency. AI-powered dose prediction platforms are software solutions used to analyze imaging and anatomical data, generate clinically achievable 3D dose distributions, and support timely adjustments to optimize therapy. For instance, in March 2025, MVision AI, a Finland-based health-tech company, launched Dose+. This AI-powered dose prediction platform incorporates specialized models for prostate and pelvic lymph node cases, tailors dose distributions to each patient's anatomy, and supports integration with standard treatment planning systems via DICOM to facilitate efficient planning workflows. This launch represents a significant technological advancement by integrating AI-driven dose prediction into routine clinical practice, bridging traditional planning with automated, patient-specific optimization, and providing clinicians with a scalable, efficient solution for precise, personalized radiation therapy.

In October 2024, Baylor College of Medicine, a US-based academic health science center, partnered with mVIZION.ai Inc. to advance AI innovations in radiation therapy planning and delivery. Through this collaboration, Baylor College of Medicine and mVIZION.ai aim to develop and refine AI-powered radiation dose scheduling and optimization tools that support personalized treatment regimens, reduce variability in therapy delivery, and improve clinical outcomes in oncology care. mVIZION.ai Inc. is a US-based artificial intelligence healthcare company.

Major companies operating in the artificial intelligence (AI) tele-oncology radiation dose scheduler market are IBM Corporation, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Varian Medical Systems Inc., Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., Accuray Incorporated, Brainlab AG, RaySearch Laboratories AB, MIM Software Inc., Sun Nuclear Corp., DeepHealth, Radformation Inc., MVision AI Ltd., Mirada Medical Ltd., ViewRay Inc., Oncora Medical, Enlitic, Optellum Ltd.

North America was the largest region in the AI tele-oncology radiation dose scheduler market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) tele-oncology radiation dose scheduler market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) tele-oncology radiation dose scheduler market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) tele-oncology radiation dose scheduler market consists of revenues earned by entities by providing services such as remote radiation dose planning services, AI-driven treatment scheduling, tele-consultation support for oncology dosing, cloud-based radiation planning assistance and real-time dose adjustment analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) tele-oncology radiation dose scheduler market consists of sales of AI radiation planning software, tele-oncology workflow platforms, cloud-based dose scheduling tools, automated treatment optimization algorithms, and radiation dose calculation systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai) tele-oncology radiation dose scheduler market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) tele-oncology radiation dose scheduler ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) tele-oncology radiation dose scheduler market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Software; Hardware; Services
• 2) By Technology: Machine Learning Algorithms; Natural Language Processing; Computer Vision; Predictive Analytics
• 3) By Deployment Mode: On-Premise (Local Installation); Cloud-Based (SaaS); Hybrid Deployment
• 4) By Application: Auto-Contouring And Segmentation (OAR Or Target); Treatment Plan Generation And Optimization; Dose Prediction And Quality Assurance (QA); Workflow And Resource Scheduling Optimization; Adaptive Radiotherapy Planning
• 5) By End-User: Hospitals; Cancer Treatment Centers; Research Institutes; Other End-Users
• Subsegments:
• 1) By Software: Analytics And Reporting Software; Recommendation Engine Software; Natural Language Processing Software; Machine Learning Model Management Tools; Computer Vision Software; Integration And API Management Software; Mobile And Web Application Software
• 2) By Hardware: AI-Optimized Servers; Edge Computing Devices; Sensors And IoT Devices; Smart Cameras; GPUs And AI Accelerators; Storage Systems; Networking And Connectivity Hardware
• 3) By Services: Consulting Services; Implementation And Integration Services; Training And Support Services; Managed AI Services; Maintenance And Upgradation Services; Custom AI Development Services; Data Management And Annotation Services
• Companies Mentioned: IBM Corporation; Siemens Healthineers AG; GE HealthCare Technologies Inc.; Koninklijke Philips N.V.; Varian Medical Systems Inc.; Elekta AB; Shanghai United Imaging Healthcare Co. Ltd.; Accuray Incorporated; Brainlab AG; RaySearch Laboratories AB; MIM Software Inc.; Sun Nuclear Corp.; DeepHealth; Radformation Inc.; MVision AI Ltd.; Mirada Medical Ltd.; ViewRay Inc.; Oncora Medical; Enlitic; Optellum Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Autonomous Systems, Robotics & Smart Mobility
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Remote Treatment Planning Optimization
  • 4.2.2 Predictive Radiation Dose Scheduling
  • 4.2.3 Adaptive Radiotherapy Integration
  • 4.2.4 Clinical Workflow Automation
  • 4.2.5 Ai-Based Patient Outcome Analytics

5. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Cancer Treatment Centers
• 5.3 Research Institutes
• 5.4 Oncology Clinics
• 5.5 Telemedicine Service Providers

6. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Segmentation

• 9.1. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Software, Hardware, Services
• 9.2. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Machine Learning Algorithms, Natural Language Processing, Computer Vision, Predictive Analytics
• 9.3. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• On-Premise (Local Installation), Cloud-Based (SaaS), Hybrid Deployment
• 9.4. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Auto-Contouring And Segmentation (OAR Or Target), Treatment Plan Generation And Optimization, Dose Prediction And Quality Assurance (QA), Workflow And Resource Scheduling Optimization, Adaptive Radiotherapy Planning
• 9.5. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Cancer Treatment Centers, Research Institutes, Other End-Users
• 9.6. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Analytics And Reporting Software, Recommendation Engine Software, Natural Language Processing Software, Machine Learning Model Management Tools, Computer Vision Software, Integration And API Management Software, Mobile And Web Application Software
• 9.7. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• AI-Optimized Servers, Edge Computing Devices, Sensors And IoT Devices, Smart Cameras, GPUs And AI Accelerators, Storage Systems, Networking And Connectivity Hardware
• 9.8. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Consulting Services, Implementation And Integration Services, Training And Support Services, Managed AI Services, Maintenance And Upgradation Services, Custom AI Development Services, Data Management And Annotation Services

10. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Regional And Country Analysis

• 10.1. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 11.1. Asia-Pacific Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 12.1. China Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 13.1. India Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 14.1. Japan Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 15.1. Australia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 16.1. Indonesia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 17.1. South Korea Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 18.1. Taiwan Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 19.1. South East Asia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 20.1. Western Europe Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 21.1. UK Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 22.1. Germany Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 23.1. France Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 24.1. Italy Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 25.1. Spain Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 26.1. Eastern Europe Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 27.1. Russia Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 28.1. North America Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 29.1. USA Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 30.1. Canada Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 31.1. South America Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 32.1. Brazil Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 33.1. Middle East Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

• 34.1. Africa Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Regulatory and Investment Landscape

36. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Competitive Landscape And Company Profiles

• 36.1. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Company Profiles
  • 36.3.1. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Other Major And Innovative Companies

• Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., Accuray Incorporated, Brainlab AG, RaySearch Laboratories AB, MIM Software Inc., Sun Nuclear Corp., DeepHealth, Radformation Inc., MVision AI Ltd., Mirada Medical Ltd., ViewRay Inc., Oncora Medical, Enlitic, Optellum Ltd.

38. Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market

40. Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market High Potential Countries, Segments and Strategies

• 40.1 Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer